These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 4843170)

  • 1. The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines.
    Yang HY; Neff NH
    J Pharmacol Exp Ther; 1974 Jun; 189(3):733-40. PubMed ID: 4843170
    [No Abstract]   [Full Text] [Related]  

  • 2. The metabolism of indolealkylamines by type A and B monoamine oxidase of brain.
    Neff NH; Yang HY; Goridis C; Bialek D
    Adv Biochem Psychopharmacol; 1974; 11(0):51-8. PubMed ID: 4845688
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of hypoxia on monoamine synthesis, levels and metabolism in rat brain.
    Davis JN; Carlsson A
    J Neurochem; 1973 Oct; 21(4):783-90. PubMed ID: 4148239
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of perturbation of cerebral amine metabolism on operationally defined learning and memory processes of goldfish.
    Stahl SM; Narotzky RA; Boshes B; Zeller EA
    Biol Psychiatry; 1974 Dec; 9(3):295-323. PubMed ID: 4441577
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of the optical isomers of the narcotic antagonist analgesic pentazocine on brain and heart biogenic amines.
    Berkowitz BA
    Eur J Pharmacol; 1974 May; 26(2):359-65. PubMed ID: 4152866
    [No Abstract]   [Full Text] [Related]  

  • 6. Drugs affecting monoamines in the basal ganglia.
    Bartholini G; Pletscher A
    Adv Biochem Psychopharmacol; 1972; 6():135-48. PubMed ID: 4560163
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of two synthetic ACTH analogues on the metabolism of biogenic amines in the rat brain.
    Leonard BE
    Arch Int Pharmacodyn Ther; 1974 Feb; 207(2):242-53. PubMed ID: 4363855
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of selective monoamine oxidase inhibitors on rat brain mitochondrial monoamine oxidase during hyperbaric oxygenation.
    Goroshinskaya IA; Bronovizkaya ZG; Gorkin VZ
    Commun Psychopharmacol; 1977; 1(1):39-47. PubMed ID: 606471
    [No Abstract]   [Full Text] [Related]  

  • 9. Stereoisomers of viminol: catalepsy and brain monoamine turnover rate.
    Costa E; Cheney D; Revuelta A
    Adv Biochem Psychopharmacol; 1973; 8(0):483-94. PubMed ID: 4800183
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of a butyrophenone derivative, U-32,802A, on brain biogenic amines.
    Lahti RA; Lednicer D
    Biochem Pharmacol; 1974 Jun; 23(12):1701-5. PubMed ID: 4842658
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of amantadine on radiolabeled biogenic amines in the rat brain.
    Symchowicz S; Korduba CA; Veals J
    Eur J Pharmacol; 1973 Feb; 21(2):155-60. PubMed ID: 4696098
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice.
    Fuller RW; Hemrick-Luecke SK; Snoddy HD
    J Pharmacol Exp Ther; 1994 Apr; 269(1):132-6. PubMed ID: 7513356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of meclofenoxate on the level and turnover of biogenic monoamines in the rat brain.
    Petkov VV; Grahovska T; Petkov VD; Konstantinova E
    Arzneimittelforschung; 1985; 35(12):1778-81. PubMed ID: 2420335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of N-cyclopropyl-4-chloroamphetamine on brain serotonin metabolism in rats.
    Fuller RW; Molloy BB
    Res Commun Chem Pathol Pharmacol; 1973 Sep; 6(2):407-18. PubMed ID: 4750092
    [No Abstract]   [Full Text] [Related]  

  • 15. [Disorders of oxidative deamination of biogenic amines in the myocardium in experimental atherosclerosis].
    Brusova EG; Krivchenkova RS
    Vopr Med Khim; 1979; 25(2):198-204. PubMed ID: 442591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in kinetics of deaminated biogenic amines in spontaneous hypertension].
    Ioffina DI; Smirnov IE; Gorkin VZ
    Vopr Med Khim; 1991; 37(1):59-63. PubMed ID: 1858344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Selective inhibition of type A monoamine oxidase by pyrazidol].
    Mashkovskiĭ MD; Gorkin VZ; Verevkina IV; Asnina VV; Tupikina SM
    Biull Eksp Biol Med; 1981 Feb; 91(2):169-71. PubMed ID: 7225552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings: Turnover of biogenic amines after acute and chronic morphine treatment in rats.
    Theiss P; Papeschi R
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R98. PubMed ID: 4276659
    [No Abstract]   [Full Text] [Related]  

  • 19. Biogenic amine-containing neurons: biochemical mechanisms of synaptic transmission.
    Neff NG; Yang HY; Garelis E; Sampath SS
    Psychother Psychosom; 1974; 23(1-6):159-68. PubMed ID: 4369812
    [No Abstract]   [Full Text] [Related]  

  • 20. Deamination of beta-phenylethylamine by monoamine oxidase--inhibition by imipramine.
    Roth JA; Gillis CN
    Biochem Pharmacol; 1974 Sep; 23(18):2537-45. PubMed ID: 4412708
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 30.